Article By:
Fred Fuld III
Sunday, June 25, 2023 3:01 PM EDT
CRISPR Therapeutics continues to be at the forefront of CRISPR-based therapeutics development. It's the first, and largest, but not the only player.
Market Forecasts For 4th Quarter 2021 And Beyond
I did not list in the Tickers covered portion 3 stocks mentioned in the article with purchase recommendations: AMC Entertainment ($AMC), Intella Theraputics ($NTLA) and SolarEdge Tech. ($SEDG). Please excuse the oversight. All the reports are available free of charge.